Marc Nasoff

Dr. Nasoff is a scientific advisor at Onchilles. He brings more than 35 years of industry experience to Onchilles and has authored more than 50 patents and 30 scientific publications. In addition to Onchilles, Dr. Nasoff is a TRACTr developer at Janux Therapeutics. Prior to Janux Therapeutics, he served as Chief Scientific Officer at Fortis Therapeutics. Before that, Dr. Nasoff was director of biologics at GNF, a subsidiary of Novartis Pharmaceuticals. He also was research director for Pharmacia Corporation and worked at Genetics Institute, Inc. in Boston. Dr. Nasoff earned his Ph.D. in microbial genetics from the University of Maryland. He also completed postdoctoral training in organic synthesis at the University of Colorado.